Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep1038 | Thyroid (non-cancer) | ECE2016

At least 15 mCi radioactive iodine dose should be considered in Graves’ disease with larger goiter: A sonographic volumetric study

Kim Jungmin , Jeong Yunah , Yoon Jee Hee , Kim Hee Kyung , Kang Ho-Cheol

Background: Fixed-dose radioactive iodine therapy (RAI) is one of the standard therapy for Graves’ disease (GD). However, optimal RAI dose to achieve hypothyroidism in GD has been controversial.Methods: The clinical outcome of 124 patients with GD treated with a RAI between Apr. 2004 and Dec. 2014 was analyzed retrospectively. Responder group was defined as patients who were rendered hypothyroid by the RAI. Thyroid volume (TV) was assessed with sono...

ea0092ps2-14-03 | Case Reports 1 | ETA2023

Two cases of radioactive iodine refractory malignant struma ovarii with nras mutation

Yoo Jungmin , Kim ChaeA , Yong Kim Tae , Bae Kim Won , Eun Song Dong , Gu Kim Won

Background: Struma ovarii is a germ cell tumor of the ovary containing ≥ 50% thyroid tissue and malignant struma ovarii (MSO) is a very rare disease containing papillary or follicular thyroid carcinomas (FTC). There is no consensus on optimal management for patients with MSO and no data on radioactive iodine (RAI) responsiveness. Here, we report two cases with RAI refractory MSO with NRAS mutation detected by next-generation sequencing (NGS). Case ...